CCL5 and Parkinson disease: Findings from 25 peer-reviewed publications, including 1,547 PD patients, and 1,107 healthy controls, confirmed that patients present an increased inflammatory-prone response and allowed the identification of elevated levels of pro-inflammatory factors, including RANTES Il-1β, Il-2, Il-6, TNF-α, and C-reactive protein.